Trial Profile
A safety, pharmacokinetics and pharmacodynamics study of CPL-2009-0031 in healthy volunteers and patients with Type 2 Diabetes mellitus (T2DM).
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jan 2019
Price :
$35
*
At a glance
- Drugs CPL 2009-0031 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Cadila Pharmaceuticals
- 14 Jan 2019 Status changed from not yet recruiting to completed.
- 29 Aug 2016 New trial record